{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:13:39Z","timestamp":1786119219428,"version":"build-2736575974"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1097\/qco.0b013e328307c7d9","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T14:09:32Z","timestamp":1236262172000},"page":"409-414","source":"Crossref","is-referenced-by-count":22,"title":["Primary antifungal prophylaxis in hematopoietic stem cell transplant recipients: clinical implications of recent studies"],"prefix":"10.1097","volume":"21","author":[{"given":"Kieren A","family":"Marr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210205","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/infdis\/171.6.1545","article-title":"Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation: a prospective, randomized, double-blind study","volume":"171","author":"Slavin","year":"1995","journal-title":"J Infect Dis"},{"key":"R2-13-20210205","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1056\/NEJM199203263261301","article-title":"A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation","volume":"326","author":"Goodman","year":"1992","journal-title":"N Engl J Med"},{"key":"R3-13-20210205","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1182\/blood.V96.6.2055","article-title":"Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial","volume":"96","author":"Marr","year":"2000","journal-title":"Blood"},{"key":"R4-13-20210205","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-138-9-200305060-00006","article-title":"Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial","volume":"138","author":"Winston","year":"2003","journal-title":"Ann Intern Med"},{"key":"R8-13-20210205","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1182\/blood-2003-08-2644","article-title":"Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants","volume":"103","author":"Marr","year":"2004","journal-title":"Blood"},{"key":"R9-13-20210205","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1182\/blood-2003-07-2512","article-title":"Cyclophosphamide metabolism is affected by azole antifungals","volume":"103","author":"Marr","year":"2004","journal-title":"Blood"},{"key":"R10-13-20210205","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.bbmt.2007.03.005","article-title":"Fluconazole coadministration concurrent with cyclophosphamide conditioning may reduce regimen-related toxicity postmyeloablative hematopoietic cell transplantation","volume":"13","author":"Upton","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"R11-13-20210205","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.bbmt.2007.08.049","article-title":"Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus-host disease","volume":"13","author":"van Burik","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"R12-13-20210205","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/MD.0b013e31815c52b0","article-title":"Infections in 100 cord blood transplantations: spectrum of early and late posttransplant infections in adult and pediatric patients 1996\u20132005","volume":"86","author":"Safdar","year":"2007","journal-title":"Medicine (Baltimore)"},{"key":"R13-13-20210205","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1182\/blood-2007-05-090928","article-title":"Polymorphisms in the chemokine (C-X-C motif) ligand 10 are associated with invasive aspergillosis after allogeneic stem-cell transplantation and influence CXCL10 expression in monocyte-derived dendritic cells","volume":"111","author":"Mezger","year":"2008","journal-title":"Blood"},{"key":"R14-13-20210205","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1469-0691.2007.01902.x","article-title":"Investigation of promoter variations in dendritic cell-specific ICAM3-grabbing nonintegrin (DC-SIGN) (CD209) and their relevance for human cytomegalovirus reactivation and disease after allogeneic stem-cell transplantation","volume":"14","author":"Mezger","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"R15-13-20210205","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1086\/422312","article-title":"Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation","volume":"39","author":"van Burik","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R16-13-20210205","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1592\/phco.27.12.1644","article-title":"Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients","volume":"27","author":"Chou","year":"2007","journal-title":"Pharmacotherapy"},{"key":"R17-13-20210205","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ijantimicag.2007.07.026","article-title":"Breakthrough invasive aspergillosis in allogeneic haematopoietic stem cell transplant recipients treated with caspofungin","volume":"30","author":"Madureira","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"R18-13-20210205","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/jac\/dkm453","article-title":"Emergence of Candida tropicalis resistant to caspofungin","volume":"61","author":"Pasquale","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"R19-13-20210205","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1128\/AAC.00067-07","article-title":"Acquired echinocandin resistance in a Candida krusei isolate due to modification of glucan synthase","volume":"51","author":"Kahn","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"R20-13-20210205","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/jac\/dkm095","article-title":"Acquired resistance to echinocandins in Candida albicans: case report and review","volume":"59","author":"Baixench","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"R22-13-20210205","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.bbmt.2007.02.012","article-title":"Invasive fungal infection following reduced-intensity cord blood transplantation for adult patients with hematologic diseases","volume":"13","author":"Miyakoshi","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"R23-13-20210205","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1532\/IJH97.06228","article-title":"Endophthalmitis due to Trichosporon beigelii in acute leukemia","volume":"85","author":"Hara","year":"2007","journal-title":"Int J Hematol"},{"key":"R24-13-20210205","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1086\/500323","article-title":"Breakthrough trichosporonosis in patients with hematologic malignancies receiving micafungin","volume":"42","author":"Matsue","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R25-13-20210205","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/pbc.21239","article-title":"Liposomal amphotericin B prophylaxis of invasive mold infections in children post allogeneic stem cell transplantation","volume":"50","author":"Roman","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"R26-13-20210205","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1439-0507.2006.01264.x","article-title":"Delayed ABLC prophylaxis after allogeneic stem-cell transplantation","volume":"49","author":"Jansen","year":"2006","journal-title":"Mycoses"},{"key":"R27-13-20210205","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijantimicag.2007.10.001","article-title":"Safety of a weekly high dose of liposomal amphotericin B for prophylaxis of invasive fungal infection in immunocompromised patients: PROPHYSOME Study","volume":"31","author":"Cordonnier","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"R28-13-20210205","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/sj.bmt.1705592","article-title":"High-dose weekly liposomal amphotericin B antifungal prophylaxis following reduced-intensity conditioning allogeneic stem cell transplantation","volume":"39","author":"El-Cheikh","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"R29-13-20210205","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bbmt.2005.10.010","article-title":"High-dose weekly AmBisome antifungal prophylaxis in pediatric patients undergoing hematopoietic stem cell transplantation: a pharmacokinetic study","volume":"12","author":"Mehta","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"R30-13-20210205","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1345\/aph.1G477","article-title":"Inhaled amphotericin B for prophylaxis against invasive Aspergillus infections","volume":"40","author":"Mohammad","year":"2006","journal-title":"Ann Pharmacother"},{"key":"R31-13-20210205","first-page":"383","article-title":"Amphotericin B and pulmonary surfactant","volume":"3","author":"Griese","year":"1998","journal-title":"Eur J Med Res"},{"key":"R32-13-20210205","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1399-3062.2006.00125.x","article-title":"Noncomparative evaluation of the safety of aerosolized amphotericin B lipid complex in patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"8","author":"Alexander","year":"2006","journal-title":"Transpl Infect Dis"},{"key":"R33-13-20210205","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1086\/586739","article-title":"Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial","volume":"46","author":"Rijnders","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R34-13-20210205","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa061098","article-title":"Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease","volume":"356","author":"Ullmann","year":"2007","journal-title":"N Engl J Med"},{"key":"R35-13-20210205","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMoa061094","article-title":"Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia","volume":"356","author":"Cornely","year":"2007","journal-title":"N Engl J Med"},{"key":"R36-13-20210205","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1592\/phco.27.12.1627","article-title":"Pharmacokinetics of oral posaconazole in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease","volume":"27","author":"Krishna","year":"2007","journal-title":"Pharmacotherapy"},{"issue":"Suppl 6","key":"R37-13-20210205","doi-asserted-by":"crossref","first-page":"S381","DOI":"10.1086\/430920","article-title":"Design issues in studies evaluating diagnostic tests for aspergillosis.","volume":"41","author":"Marr","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R39-13-20210205","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.diagmicrobio.2006.01.018","article-title":"Incidence of invasive aspergillosis among allogeneic hematopoietic stem cell transplant patients receiving voriconazole prophylaxis","volume":"55","author":"Siwek","year":"2006","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R40-13-20210205","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/sj.bmt.1705754","article-title":"Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole","volume":"40","author":"Trifilio","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"R41-13-20210205","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/cncr.22568","article-title":"Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipients","volume":"109","author":"Trifilio","year":"2007","journal-title":"Cancer"},{"key":"R42-13-20210205","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1086\/422723","article-title":"Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis","volume":"39","author":"Siwek","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R43-13-20210205","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/sj.bmt.1705614","article-title":"Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy","volume":"39","author":"Trifilio","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"R44-13-20210205","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1086\/313803","article-title":"Zygomycosis in the 1990s in a tertiary care center","volume":"30","author":"Kontoyiannis","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R45-13-20210205","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1056\/NEJM200402263500923","article-title":"Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants","volume":"350","author":"Marty","year":"2004","journal-title":"N Engl J Med"},{"key":"R46-13-20210205","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1086\/423274","article-title":"Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole","volume":"39","author":"Imhof","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R47-13-20210205","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.bbmt.2005.12.032","article-title":"Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation","volume":"12","author":"Marty","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"R48-13-20210205","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1086\/429921","article-title":"Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay","volume":"40","author":"Marr","year":"2005","journal-title":"Clin Infect Dis"}],"container-title":["Current Opinion in Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/QCO.0b013e328307c7d9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:46:33Z","timestamp":1786038393000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001432-200808000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/qco.0b013e328307c7d9","relation":{},"ISSN":["0951-7375"],"issn-type":[{"value":"0951-7375","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}